Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Hypertension. 2016 Feb 1;67(3):623–629. doi: 10.1161/HYPERTENSIONAHA.115.06565

Table 2.

Physiological data for wild-type (WT) and MMP9-deficient mice treated with angiotensin II (Ang II) (1000ng/kg/min) or saline for 4 weeks. Systolic arterial pressure was measured by tail cuff method in conscious mice at week 4 of Ang II treatment. Pial arteriolar pressure was measured under anesthetized condition.

Parameters WT
Saline
WT
Ang II
MMP9−/−
Saline
MMP9−/−
Ang II
Systolic Arterial Pressure (mmHg)
  Week 4 114 ± 5 154 ± 6* 117 ± 4 157 ± 4*
Pial arteriolar pressure (mmHg)
  Systolic 48 ± 4 41 ± 5 51 ± 4 46 ± 2
  Diastolic 34 ± 4 30 ± 4 38 ± 2 32 ± 2
  Mean 38 ± 4 34 ± 4 42 ± 3 37 ± 2
  Pulse 14 ± 1 11 ± 2 13 ± 2 13 ± 1
Arterial blood gases
  pH 7.49 ± 0.02 7.30 ± 0.03 7.30 ± 0.04 7.47 ± 0.02
  PCO2 22 ± 2 44 ± 4 35 ± 2 28 ± 5
  PO2 168 ± 4 97 ± 5 122 ± 2 136 ± 6
Age (week) 13 ± 0.3 17 0.8 12 ± 0.4 18 ± 0.5
Weight (g) 25.0 ± 0.9 24.5 ± 1.4 26.6 ± 1.2 23.9 ± 1.1
N 6 6 6 6

Values are mean±SEM.

*

P<0.05 versus corresponding saline controls.